Videos

Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains a new combined CT-angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA approval. The Alphenix 4D CT Insight Edition includes numerous radiation dose lowering technologies.

Canon introduces new combined CT-angiography interventional system

Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains the technology behind a new combined CT angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA clearance.

Canon Medical is launching new X-ray advances at the Radiological Society of North America (RSNA) 2025 annual meeting. This includes the advanced artificial intelligence Clear-IQ technology to boost diagnostic image quality of low-dose images, and the new Adora DRFi low-dose fluoroscopy system. Canon will also highlight the patented technology built into its premium mobile X-ray solution, the SOLTUS 500.

Canon shows new X-ray imaging advances at RSNA 2025

Sponsored by Canon Medical Systems USA, Inc.

Canon Medical is launching new X-ray advances at the Radiological Society of North America (RSNA) 2025 annual meeting.

Society of Cardiovascular Angiography and Interventions (SCAI) President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explains the SCAI initiative to improve outcomes in cardiogenic shock by monitoring and lowering patient lactate levels.

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data. 

Samuel Horr

How TriStar Health leveraged AI to enhance care for pulmonary embolism patients

Sponsored by Viz.ai

Pulmonary embolism (PE) treatment has evolved over time, yet it remains the third leading cause of cardiovascular death across the United States. TriStar Health, a comprehensive health system serving Tennessee and Kentucky and part of HCA Healthcare, is now using an AI platform to support clinicians in providing more effective care for PE patients.

 SCAI President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explained some of the key payment issues interventional cardiologists are facing amid declining Medicare reimbursements.

SCAI fighting for interventional cardiologists amid challenging payment policies

SCAI President Srihari Naidu, MD, detailed some of the challenges interventional cardiologists face as reimbursements keep declining. The group has been building new partnerships with other medical societies to strengthen its influence in Washington. 

Sahil Parikh, MD, director of endovascular services, Columbia University Irving Medical Center, associate professor of medicine at Columbia University, and a program director for the Transcatheter Cardiovascular Therapeutics (TCT) meeting, explains the growing focus in interventional cardiology on endovascular procedures for stroke, pulmonary embolism, peripheral artery disease and renal denervation.

Interventional cardiology showing more interest in endovascular procedures

Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.

Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.

CCTA will play an essential role in the cath labs of the future

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview. 

Video Robert Lookstein on mechanical thrombectomy beating anticoagulation alone in pulmonary embolism in the late-breaking STORM-PE trial at TCT 2025.

Mechanical thrombectomy beats anticoagulation alone in STORM-PE

Highly anticipated trial data comparing mechanical thrombectomy to anticoagulation alone for intermediate- and high-risk pulmonary embolism showed that the more aggressive strategy improved outcomes.